Arfaptin 1 inhibits ADP-ribosylation factor-dependent matrix metalloproteinase-9 secretion induced by phorbol ester in HT 1080 fibrosarcoma cells

FEBS Lett. 2003 Feb 27;537(1-3):91-5. doi: 10.1016/s0014-5793(03)00098-x.

Abstract

Matrix metalloproteinase-9 (MMP-9) is a collagenolytic enzyme secreted by cancer cells and involved in invasiveness and metastasis. Its secretion from human fibrosarcoma HT 1080 cells is markedly enhanced by phorbol 12-myristate 13-acetate (PMA) and abolished by brefeldin A, an inhibitor of ADP-ribosylation factor (ARF) activation. These results support a role for ARF in PMA-stimulated MMP-9 secretion. Overexpression of arfaptin 1, a 39 kDa ARF-binding protein that inhibits in vitro activation of cholera toxin ADP-ribosyltransferase and phospholipase D (PLD) by ARF, inhibited PMA-stimulated MMP-9 and PLD activation. These data are in agreement with previous results demonstrating a significant role for PLD in regulating MMP-9 secretion.

MeSH terms

  • ADP-Ribosylation Factors / antagonists & inhibitors*
  • Adaptor Proteins, Signal Transducing*
  • Brefeldin A / pharmacology
  • Carrier Proteins / genetics
  • Carrier Proteins / physiology*
  • Fibrosarcoma
  • Humans
  • Kinetics
  • Matrix Metalloproteinase 9 / metabolism*
  • Tetradecanoylphorbol Acetate / pharmacology*
  • Tumor Cells, Cultured

Substances

  • ARFIP1 protein, human
  • Adaptor Proteins, Signal Transducing
  • Carrier Proteins
  • Brefeldin A
  • Matrix Metalloproteinase 9
  • ADP-Ribosylation Factors
  • Tetradecanoylphorbol Acetate